1. Background
2. Objectives
3. Methods
3.1. Statistical Analysis
4. Results
| Variables | Total | Insufficient Diagonal Flow (N = 13) | Sufficient Diagonal Flow (N = 94) | P-Value |
|---|---|---|---|---|
| Age (y) | 58.78 ± 12.28 | 56.53 ± 12.35 | 59.09 ± 12.31 | 0.48 |
| Men | 90 (84.1) | 10 (76.9) | 80 (85.1) | 0.43 |
| Hypertension | 59 (55.1) | 7 (53.8) | 52 (55.3) | 0.92 |
| Diabetes mellitus | 23 (21.5) | 3 (23.1) | 20 (21.3) | 0.56 |
| Smoking | 49 (45.8) | 3 (23.1) | 46 (48.9) | 0.07 |
| Chronic kidney disease | 6 (5.6) | 1 (7.7) | 5 (5.3) | 0.54 |
| Hyperlipidemia | 11 (10.3) | 2 (15.4) | 9 (9.6) | 0.39 |
| ST-segment resolution > 50% | 84 (79.2) | 9 (69.2) | 75 (80.6) | 0.34 |
| Killip class | 0.10 | |||
| I | 89 (83.2) | 8 (61.5) | 81 (86.2) | |
| II | 13 (12.1) | 3 (23.1) | 10 (10.6) | |
| III | 3 (2.8) | 1 (7.7) | 2 (2.1) | |
| IV | 2 (1.9) | 1 (7.7) | 1 (1.1) | |
| Systolic blood pressure at admission (mmHg) | 146.89 ± 29.53 | 128.07 ± 23.58 | 149.5 ± 29.43 | 0.01 b |
| Diastolic blood pressure at admission (mmHg) | 78.71 ± 11.86 | 76.92 ± 9.25 | 78.94 ± 12.21 | 0.56 |
| Heart rate (bpm) | 94.11 ± 14.66 | 102.38 ± 11.03 | 92.94 ± 14.78 | 0.02 b |
| Laboratory finding | ||||
| Hemoglobin (g/dL) | 14.36 ± 1.61 | 14.66 ± 1.35 | 14.31 ± 1.65 | 0.47 |
| Platelet count (109/ L) | 256168 ± 82911 | 322500 ± 86988 | 246896 ± 78422 | 0.002 b |
| Serum creatinine (mg/dL) | 1.12 ± 0.22 | 1.19 ± 0.21 | 1.11 ± 0.22 | 0.20 |
| Glucose (mg/dL) | 142.52 ± 56.39 | 133.23 ± 25.55 | 143.81 ± 59.38 | 0.52 |
| Peak cardiac troponin (ng/mL) | 16.95 ± 10.18 | 22.63 ± 6.12 | 16.16 ± 10.41 | 0.03 b |
| Medications post-procedure | ||||
| ASA | 107 (100) | 13 (100) | 94 (100) | - |
| Clopidogrel | 107 (100) | 13 (100) | 94 (100) | - |
| Beta blocker | 64 (40.2) | 5 (38.5) | 59 (62.8) | 0.094 |
| Statin | 107 (100) | 13 (100) | 94 (100) | - |
| ACE or ARB | 107 (100) | 13 (100) | 94 (100) | - |
| Diuretic | 50 (46.27) | 9 (69.2) | 41 (43.6) | 0.083 |
Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; bpm, beat per minute.
a Values are expressed as mean ± SD or No. (%).
b Statistical significance was set at a level of 0.05.
| Variables | Total | Insufficient Diagonal Flow (N = 13) | Sufficient Diagonal Flow (N = 94) | P-Value |
|---|---|---|---|---|
| Vessel number | 0.252 | |||
| 1VD | 56 (52.3) | 9 (69.2) | 47 (50) | |
| 2VD | 28 (26.2) | 1 (7.7) | 27 (28.7) | |
| 3VD | 23 (21.5) | 3 (23.1) | 20 (21.3) | |
| Proximal LAD occlusion | 42 (39.3) | 9 (69.2) | 33 (35.1) | 0.018 b |
| Mid LAD occlusion | 65 (60.7) | 4 (30.8) | 61 (64.9) | |
| Door-to-balloon time, minutes | 43.87 ± 17.94 | 41.38 ± 19.13 | 44.22 ± 17.84 | 0.595 |
| Total ischemic time, minutes | 177.03 ± 105.61 | 164.53 ± 59.71 | 178.76 ± 110.58 | 0.651 |
| Contrast volume, milliliter | 210.61 ± 75.76 | 226.92 ± 91.77 | 208.3 ± 73.54 | 0.410 |
| Thrombosuction | 2 (1.9) | 0 | 2 (2.1) | 0.771 |
| Eptifibatide | 89 (83.2) | 13 (100) | 76 (80.9) | 0.078 |
| Low thrombus burden | 18 (16.9) | 1 (7.7) | 17 (18.1) | 0.69 |
| High thrombus burden | 89 (83.1) | 12 (92.3) | 77 (81.9) | |
| Stent length (millimeter) | 22.52 ± 6.61 | 21.92 ± 6.57 | 22.61 ± 6.64 | 0.728 |
| Stent diameter (millimeter) | 3.21 ± 0.39 | 3.42 ± 0.53 | 3.17 ± 1.36 | 0.029 b |
| Initial LAD TIMI 0, 1 | 85 (79.4) | 13 (100) | 72 (76.5) | 0.06 |
| Final LAD TIMI < 3 | 22 (20.5) | 13 (100) | 8 (8.5) | < 0.0001 b |
| Initial diagonal TIMI 0, 1 | 48 (44.8) | 13 (100) | 35 (37.2) | < 0.0001 b |
Abbreviations: LAD, left anterior descending artery; TIMI, thrombolysis in myocardial infarction.
aValues are expressed as mean ± SD or No. (%).
b Statistical significance was set at a level of 0.05.
| Variables | Total | Insufficient Diagonal Flow (N = 13) | Sufficient Diagonal Flow (N = 94) | P-Value |
|---|---|---|---|---|
| BSA (m2) | 1.85 ± 0.18 | 1.82 ± 0.12 | 1.86 ± 0.19 | 0.488 |
| LVEDD (mm) | 4.68 ± 0.49 | 4.72 ± 0.51 | 4.67 ± 0.49 | 0.754 |
| LVESV(mL) | 79.88 ± 20.75 | 85.53 ± 17.58 | 79.10 ± 21.11 | 0.155 |
| LVEF (%) | 38.26 ± 8.73 | 32.92 ± 7.29 | 39 ± 8.68 | 0.018 a |
| LAV (mL) | 51.53 ± 15.41 | 57.34 ± 22.98 | 50.73 ± 14.02 | 0.310 |
| LVESD, (mm) | 3.25 ± 0.62 | 3.42 ± 0.67 | 3.23 ± 0.61 | 0.448 |
| LVEDV,(mL) | 50.18 ± 19.61 | 57.84 ± 16.65 | 49.12 ± 19.83 | 0.042 a |
| FS (%) | 30.18 ± 8.53 | 27.61 ± 7.45 | 30.54 ± 8.65 | 0.249 |
| LAVI (mL/m2) | 27.99 ± 8.67 | 31.91 ± 13.83 | 27.45 ± 7.65 | 0.254 |
| LVWMSI | 1.51 ± 0.27 | 1.68 ± 0.28 | 1.49 ± 0.26 | 0.029 a |
Abbreviations: BSA, body surface area; FS, fractional shortening; LAV, left atrial volume; LAVI, left atrial volume index; LVEDD, left ventricular end-diastolic dimension; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; LVESV, left ventricular end-systolic volume; LVWMSI, Left Ventricular Wall-Motion Score Index.
a Statistical significance was set at a level of 0.05.